AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2022

Key Information As of 01/10/25

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$57.76 million
NAV	$30.24
Fact Sheet	View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 01/08/25

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	1,910,000
Number of Holdings	83
30-Day Median Bid-Ask Spread	0.36%

Distributions As of 01/10/25

30-Day SEC Yield	1.02%
Distribution Frequency	Semi-Annually

ETF Prices As of 01/10/25

NAV	$30.24	Daily Change	-$0.18	-0.59%
Market Price	$30.10	Daily Change	-$0.32	-1.05%

As of recent month & quarter-end (12/31/24) As of recent month & quarter-end (12/31/24)	Fund NAV	Market Price	Index
1 Year	6.81%	7.04%	7.21%
3 Years	2.34%	2.36%	2.65%
5 Years	5.79%	5.80%	6.07%
Since Inception	9.08%	9.34%	9.39%
1 Year	6.81%	7.04%	7.21%
3 Years	2.34%	2.36%	2.65%
5 Years	5.79%	5.80%	6.07%
Since Inception	9.08%	9.34%	9.39%
Year-to-Date	6.81%	7.04%	7.21%
1 Month	-4.90%	-5.05%	-4.86%
3 Months	-7.34%	-7.59%	-7.21%
Since Inception	112.18%	116.59%	117.32%
Year-to-Date	6.81%	7.04%	7.21%
1 Month	-4.90%	-5.05%	-4.86%
3 Months	-7.34%	-7.59%	-7.21%
Since Inception	112.18%	116.59%	117.32%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
4.01	WELL	WELLTOWER INC	BYVYHH4	124.78	18,564	2,316,415.92
4.00	BSX	BOSTON SCIENTIFIC CORP	2113434	94.88	24,369	2,312,130.72
3.63	4519 JP	CHUGAI PHARMA CO	6196408	42.75	49,075	2,098,097.95
3.42	UCB BB	UCB SA	5596991	199.97	9,878	1,975,276.02
3.30	BMY	BRISTOL-MYERS SQUIBB CO	2126335	55.83	34,150	1,906,594.50
3.07	SYK	STRYKER CORP	2853688	365.66	4,844	1,771,257.04
3.06	LLY	ELI LILLY & CO	2516152	799.90	2,208	1,766,179.20
3.04	ABBV	ABBVIE INC	B92SR70	175.17	10,013	1,753,977.21
2.97	ALC SW	ALCON INC	BJT1GR5	83.89	20,430	1,713,850.62
2.93	RO SW	ROCHE HOLDING AG-BR	7108918	313.16	5,400	1,691,090.62
2.85	MDT	MEDTRONIC PLC	BTN1Y11	80.66	20,412	1,646,431.92
2.82	AMGN	AMGEN INC	2023607	262.23	6,212	1,628,972.76
2.80	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	67.01	24,151	1,618,358.51
2.77	JNJ	JOHNSON & JOHNSON	2475833	142.06	11,273	1,601,442.38
2.53	068270 KS	CELLTRION INC	B0C5YV1	126.35	11,554	1,459,812.86
2.49	4543 JP	TERUMO CORP	6885074	18.99	75,699	1,437,310.62
2.33	EW	EDWARDS LIFESCIENCES CORP	2567116	73.42	18,347	1,347,036.74
2.20	REGN	REGENERON PHARMACEUTICALS	2730190	696.88	1,822	1,269,715.36
2.03	VTR	VENTAS INC	2927925	57.39	20,387	1,170,009.93
2.02	NOVOB DC	NOVO NORDISK A/S-B	BP6KMJ1	86.86	13,440	1,167,459.39
1.88	ZBH	ZIMMER BIOMET HO	2783815	104.54	10,388	1,085,961.52
1.82	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	130.07	8,068	1,049,381.42
1.73	SOON SW	SONOVA HOLDING AG-REG	7156036	330.41	3,017	996,833.00
1.67	PODD	INSULET CORP	B1XGNW4	271.83	3,546	963,909.18
1.62	DXCM	DEXCOM INC	B0796X4	77.76	12,008	933,742.08
1.62	SDZ SW	SANDOZ GROUP AG	BLPLD38	42.74	21,826	932,865.32
1.52	4503 JP	ASTELLAS PHARMA INC	6985383	9.58	91,841	880,060.35
1.51	UTHR	UNITED THERAPEUTICS CORP	2430412	364.97	2,383	869,723.51
1.48	ONC	BEIGENE LTD-ADR	BYYWPW6	176.71	4,843	855,806.53
1.39	INCY	INCYTE CORP	2471950	70.54	11,368	801,898.72
1.28	GMAB DC	GENMAB A/S	4595739	220.84	3,354	740,684.70
1.23	NBIX	NEUROCRINE BIOSC	2623911	140.90	5,037	709,713.30
1.18	DVA	DAVITA INC	2898087	153.40	4,440	681,096.00
1.17	FME GR	FRESENIUS MEDICAL CARE AG	5129074	45.18	14,924	674,261.44
1.08	3692 HK	HANSOH PHARMACEU	BJYKB72	2.09	299,843	625,290.57
1.07	COH AU	COCHLEAR LTD	6211798	185.40	3,318	615,170.63
0.96	EXEL	EXELIXIS INC	2576941	36.02	15,340	552,546.80
0.93	SN/ LN	SMITH & NEPHEW PLC	0922320	12.08	44,472	537,347.11
0.90	EXAS	EXACT SCIENCES CORP	2719951	56.50	9,185	518,952.50
0.79	OHI	OMEGA HEALTHCARE	2043274	36.83	12,409	457,023.47
0.78	DEMANT DC	DEMANT A/S	BZ01RF1	39.43	11,356	447,740.74
0.78	PHM SM	PHARMA MAR SA	BMW2GT8	79.13	5,656	447,536.23
0.72	TFX	TELEFLEX INC	2881407	174.61	2,387	416,794.07
0.68	GKOS	GLAUKOS CORP	BYMWL19	156.53	2,504	391,951.12
0.65	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	130.95	2,867	375,433.65
0.59	HALO	HALOZYME THERAPEUTICS INC	2975098	52.80	6,433	339,662.40
0.56	NVCR	NOVOCURE LTD	BYSS4X4	27.45	11,862	325,611.90
0.51	AMP IM	AMPLIFON SPA	B14NJ71	25.83	11,480	296,513.13
0.51	EMBC	EMBECTA CORP	BMXWYR1	19.48	15,216	296,407.68
0.49	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	96.16	2,936	282,325.76
0.47	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	87.43	3,101	271,120.43
0.44	YPSN SW	YPSOMED HOLDING AG-REG	B02SWN8	369.91	691	255,604.78
0.41	MNKD	MANNKIND CORP	BF081J4	6.09	38,960	237,266.40
0.39	ITGR	INTEGER HOLDINGS CORP	BD06LM7	133.73	1,694	226,538.62
0.35	SBRA	SABRA HEALTH CAR	B5NLBP6	16.59	12,152	201,601.68
0.33	8086 JP	NIPRO CORP	6641599	9.37	20,328	190,405.69
0.33	CSH-U CN	CHARTWELL RETIRE	B8S8C94	10.34	18,273	189,007.01
0.33	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	34.42	5,472	188,346.24
0.33	NHI	NATL HEALTH INVESTORS INC	2626125	66.22	2,844	188,329.68
0.31	NHC	NATIONAL HEALTHCARE CORP	2139731	96.85	1,865	180,625.25
0.31	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	10.22	17,266	176,436.51
0.30	LTC	LTC PROPERTIES INC	2498788	33.50	5,206	174,401.00
0.29	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	19.10	8,742	166,972.20
0.29	AMED	AMEDISYS INC	2024332	91.90	1,814	166,706.60
0.29	ACAD	ACADIA PHARMACEU	2713317	17.26	9,623	166,092.98
0.29	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	8.78	18,741	164,545.98
0.27	RYM NZ	RYMAN HEALTHCARE LTD	6161525	2.51	62,200	156,040.61
0.26	AED BB	AEDIFICA	B1G5XP1	56.53	2,689	151,997.98
0.26	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	0.68	216,302	147,765.86
0.25	LIVN	LIVANOVA PLC	BYMT0J1	46.66	3,096	144,459.36
0.23	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.54	244,489	131,545.29
0.23	GN DC	GN STORE NORD A/S	4501093	17.17	7,651	131,332.98
0.22	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	5.60	22,913	128,199.62
0.21	BKD	BROOKDALE SR	B0PZN33	4.89	25,134	122,905.26
0.21	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.26	465,424	122,519.32
0.21	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.17	734,692	121,701.79
0.21	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	9.97	11,947	119,111.59
0.19		OTHER PAYABLE & RECEIVABLES		1.00	111,427	111,426.76
0.14	145720 KS	DENTIUM CO LTD	BF07GJ6	46.55	1,774	82,587.67
0.13	AGL	AGILON HEALTH INC	BLR4TK4	2.43	31,426	76,365.18
0.08	ALEC	ALECTOR INC	BJ4LDC4	1.80	26,820	48,276.00
0.08	9229 JP	SUNWELS CO LTD	BNTYNB5	4.38	10,514	46,037.95
0.08	2500 HK	VENUS MEDTECH -H	BL6V047	0.43	102,940	44,573.19
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.02
0.00		DANISH KRONE		0.14	-308	-42.31
-0.04		CASH		1.00	-24,275	-24,275.04

Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 12/31/24

	Sector	Weight (%)
	Health Care	91.8
	Real Estate	8.3

Source: new windowAltaVista Research, LLC

	Industry	Weight (%)
	Pharmaceuticals, Biotechnology & Life Sciences	46.9
	Health Care Equipment & Services	40.5
	Equity Real Estate Investment Trusts (REITs)	8.3
	Pharmaceuticals, Biotechnology	4.4

Source: new windowAltaVista Research, LLC

	Country	Weight (%)
	United States	53.6
	Switzerland	11.3
	Japan	8.3
	Britain	4.6
	Denmark	4.2
	China	3.8
	Belgium	3.7
	Ireland	2.8
	South Korea	2.7
	Germany	1.2
	Australia	1.0
	Other	2.8

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 01/10/25

Return on Equity	13.20%
Weighted Avg. Market Cap	93,780 M
	2023	2024
Price-to-earnings	26.12	25.81
Price-to-book value	3.53	3.27

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 12/31/24

Versus	Beta
S&P 500	0.71
NASDAQ-100	0.48
MSCI EAFE	0.75
MSCI Emg. Mkts	0.49
Standard Deviation	15.50%

Source: new windowAltaVista Research, LLC

ETF Research

ETF Documents

Latest Premium / Discount As of 01/10/25

NAV	$30.24
Market Price	$30.10
Premium / (Discount)	($0.14)

Current View 2025 Q1 As of 01/10/25

Days at Premium	2
Days at NAV	0
Days at Discount	4
Greatest Premium	0.05%
Greatest Discount	-0.47%

Daily Premium / Discount History As of 01/10/25

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 01/10/25

ETF Summary

ETF Objective

Trading Details As of 01/08/25

Distributions As of 01/10/25

ETF Prices As of 01/10/25

Performance History

Top Holdings As of 01/10/25

Exposure As of 12/31/24

ETF Characteristics As of 01/10/25

ETF Risk Stats As of 12/31/24

ETF Research

Investing in Pharma: How to Spot Leading Drug Candidates

Investing in Pharma: The Drug Lifecycle

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

ETF Documents